Pincus T
Division of Rheumatology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
J Rheumatol Suppl. 1996 Oct;46:19-24; discussion 24-5.
The clinical status of patients with the eosinophilia-myalgia syndrome (EMS) was studied 2-4 years after its description in 2 databases: (1) a structured review of 205 patients with EMS completed by 15 physicians 18-24 months after onset, which included symptoms, physical findings, laboratory data, and responses to treatments; (2) a self-report questionnaire completed by 344 patients with EMS 42-48 months after onset. Most patients continued to experience symptoms, but almost none experienced new signs of acute inflammation more than one year after onset of EMS. These databases, while presenting information concerning longterm outcomes of more patients with EMS than other reported sources, remain limited by patient selection and the absence of information concerning clinical symptoms before development of EMS.
在嗜酸性粒细胞增多性肌痛综合征（EMS）被描述后的2至4年，通过两个数据库对患者的临床状况进行了研究：（1）由15名医生在发病后18至24个月完成的对205例EMS患者的结构化回顾，内容包括症状、体格检查结果、实验室数据以及对治疗的反应；（2）344例EMS患者在发病后42至48个月完成的一份自我报告问卷。大多数患者仍有症状，但在EMS发病一年后，几乎没有人出现新的急性炎症体征。这些数据库虽然提供了比其他报告来源更多的EMS患者长期预后信息，但仍受患者选择的限制，且缺乏EMS发病前临床症状的相关信息。
